Agreements reached under this partnership
Business alliance- 1
As the manufacturing and marketing authorization holder, we will support the sales alliance partner's activities by providing academic and other information.
These are items that the documents state the two companies will work on. The lines above and below represent arrangements between the two companies.
The impact of this matter is expected to be incorporated into the consolidated earnings forecasts for the fiscal year ending March 2027, which will be included in the financial results summary for the fiscal year ending March 2026, scheduled to be announced on 13 May 2026.
| Item | Details |
|---|---|
| Name of alliance partner | Covidien Japan Co., Ltd. |
| Alliance partner's business activities | The Japanese subsidiary of global medical device manufacturer Medtronic, responsible for providing solutions in the surgical, minimally invasive treatment and diagnostic fields. |
| Alliance partner's location | Minato-ku, Tokyo |
| Type of alliance | Business alliance |
| Details of the alliance | As the manufacturing and marketing authorization holder, we will support the sales alliance partner's activities by providing academic and other information. |
| Impact on Business Performance | The impact of this matter is expected to be incorporated into the consolidated earnings forecasts for the fiscal year ending March 2027, which will be included in the financial results summary for the fiscal year ending March 2026, scheduled to be announced on 13 May 2026. |
Items this document does not state (17)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Covidien Japan Co., Ltd. has a strong presence and a broad product portfolio in the main application areas, including gastrointestinal surgery and gynecology, and synergies with this material are expected.